| Madeleine Daugherty, | |
|
254 Red Cedar St, Bluffton, SC 29910-8967 | |
| (843) 815-6999 | |
| (843) 815-6998 |
| Full Name | Madeleine Daugherty |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 254 Red Cedar St, Bluffton, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073061925 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP.6032 SPIN (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Madeleine Daugherty, 254 Red Cedar St, Bluffton, SC 29910-8967 Ph: (843) 815-6999 | Madeleine Daugherty, 254 Red Cedar St, Bluffton, SC 29910-8967 Ph: (843) 815-6999 |
News Archive
KAEL-GemVax, a leading oncology vaccine company, today announced, through its subsidiary GemVax A.S, encouraging interim progress from the UK-based Phase III TeloVac study of its anti-telomerase therapeutic cancer vaccine GV1001 in pancreatic cancer. The company also strongly believes GV1001 has major "blockbuster" potential as a universal therapeutic cancer vaccine and is developing a strong pipeline for other indications, including lung and liver cancer and melanoma.
Less fatigue and better recovery of cognitive abilities such as learning and memory. These may be the results of growth hormone treatment after a stroke, an experimental study of mice published in the journal Stroke suggests.
Vanderbilt University's Treatment and Research Institute for Autism Spectrum Disorders (TRIAD) and the Tennessee Department of Education are partnering to bring a novel intervention program to families of young children with autism in Middle Tennessee.
Despite recent achievements in the development of cancer immunotherapies, only a small group of patients typically respond to them. Predictive markers of disease course and response to immunotherapy are urgently needed.
Gilead Sciences says its next generation drug to combat hepatitis C, slated to launch next month, will be more expensive than $1,000-a-pill Sovaldi, in part because the new treatment will be shorter and simpler. Gilead also struck a deal with Indian generic drugmakers to sell lower-cost versions of Sovaldi in poor countries.
› Verified 7 days ago
Mrs. Tory Irene Candea, M.S. CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 29 Plantation Park Dr, Suite #403, Bluffton, SC 29910 Phone: 843-815-6999 Fax: 843-815-6999 | |
Kathleen Marie Castrilli, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 254 Red Cedar St, Bluffton, SC 29910 Phone: 203-494-9146 | |
Kelly Amanda Barrell, M.A., SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 37 Kendall Dr, Bluffton, SC 29910 Phone: 843-540-2494 | |
Madison Marie Hatfield, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 254 Red Cedar St, Bluffton, SC 29910 Phone: 843-970-2899 | |
Mrs. Amy R Chaisson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 Fording Island Rd, Bluffton, SC 29910 Phone: 843-553-1805 | |
Sandra Ray, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 105 Farnsleigh Ave, Bluffton, SC 29910 Phone: 727-505-3677 Fax: 843-594-4084 |